Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;86(1):15-21.
doi: 10.1159/000314333. Epub 2010 Jun 23.

Effects of cholesterol and its 24S-OH and 25-OH oxysterols on choline acetyltransferase-positive neurons in brain slices

Affiliations

Effects of cholesterol and its 24S-OH and 25-OH oxysterols on choline acetyltransferase-positive neurons in brain slices

Celine Ullrich et al. Pharmacology. 2010.

Abstract

In Alzheimer's disease (AD) neurons expressing the enzyme choline acetyltransferase (ChAT) degenerate and a loss of cholinergic activity directly correlates with cognitive decline. Recent studies have suggested that cholesterol plays a role in AD. The aim of the present study was to explore if cholesterol and its oxysterols, 24S-hydroxycholesterol (24S-OH Chol) and 25-hydroxycholesterol (25-OH Chol), affect ChAT-positive neurons in organotypic brain slices of the basal nucleus of Meynert (nBM). We showed that slices expressed approximately 140 ChAT-positive neurons/slice after 2 weeks when incubated with nerve growth factor (NGF). This number markedly decreased when incubated without NGF to approximately 20 neurons/slice. Cholesterol and 24S-OH Chol delayed this decrease in ChAT-positive neurons. In contrast, 25-OH Chol induced a decline in ChAT-positive neurons in 2-week-old slices within 4 days. The effects of cholesterol and its oxysterols were exhibited in a dose- and time-dependent way. Our results show that cholesterol and 24S-OH Chol delays the decrease in ChAT-positive neurons, while 25-OH Chol rapidly decreases ChAT expression, suggesting differential mechanisms on ChAT expression in cholinergic nBM neurons.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Organotypic brain slices of the nBM were cultured with (B, E) or without (A, D) 10 ng/ml NGF or with 2 μg/ml cholesterol (C, F). After 2 weeks slices were fixed and cholinergic neurons were immunohistochemically stained against ChAT (A–F). Higher magnifications of the corresponding slices are shown in D–F. Scale bar = 350 μm (A–C), 70 μm (D–F).
Fig. 2
Fig. 2
Effects of cholesterol and 24S-OH Chol on ChAT in axotomized cholinergic brain slices (assay 1). Brain slices of the nBM were cultured without (−; ■) or with 10 ng/ml NGF (●) or with 0.02, 0.2, or 2 μg/ml cholesterol (□) (A, B) or 24S-OH Chol (▲) (C, D). After 2 weeks the slices were fixed and immunohistochemically stained against ChAT. The number of ChAT-positive neurons was counted in whole slices. Statistical analysis was performed by one-way ANOVA with a Fisher PLSD post hoc test. ***p < 0.001; *p < 0.05; NS = not significant.
Fig. 3
Fig. 3
Effects of 25-OH Chol on ChAT expression in 2-week nBM brain slices (assay 2). Slices were incubated for 2 weeks with 10 ng/ml NGF, then for 3 days without NGF and then with (NGF, filled circles) or without (−) NGF, or 0.02, 0.2, 2 μg/ml 25-OH Chol (filled triangles). After 4 days brain slices were fixed and stained for ChAT. The number of ChAT-positive neurons was counted in whole slices. Statistical analysis was performed by one-way ANOVA with a Fisher PLSD post hoc test. ***p < 0.001; **p < 0.01; NS = not significant.

Similar articles

Cited by

References

    1. Winkler J, Thal LJ, Gage FH, Fisher LJ. Cholinergic strategies for Alzheimer’s disease. J Mol Med. 1998;76:555–567. - PubMed
    1. Schliebs R, Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease. J Neural Transm. 2006;113:1625–1644. - PubMed
    1. Sassin I, Schultz C, Thal DR, Rüb U, Arai K, Braak E, Braak H. Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol. 2000;100:259–269. - PubMed
    1. Simons M, Keller P, Dichgans J, Schulz JB. Cholesterol and Alzheimer’s disease. Neurology. 2001;57:1089–1093. - PubMed
    1. Puglielli L, Tanzi RE, Kovacs DM. Alzheimer’s disease: the cholesterol connection. Nature Neurosci. 2003;6:345–351. - PubMed

Publication types